Ohcanbohtosat - Claude Preudhomme
- Čájehuvvo 1 - 20 / 100
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
17p Deletion in Acute Myeloid Leukemia and Myelodysplastic Syndrome. Analysis of Breakpoints and Deleted Segments by Fluorescence In Situ Dahkki Valérie Soenen, Claude Preudhomme, Christophe Roumier, Agnès Daudignon, Jean Luc Laı̈, Pierre Fenaux
Almmustuhtton 1998Artigo -
4
-
5
Methylation of the p15INK4b Gene in Myelodysplastic Syndromes Is Frequent and Acquired During Disease Progression Dahkki Bruno Quesnel, Gaëlle Guillerm, Rodolphe Vereecque, Eric Wattel, Claude Preudhomme, F Bauters, Michaël Vanrumbeke, Pierre Fenaux
Almmustuhtton 1998Artigo -
6
p16 gene homozygous deletions in acute lymphoblastic leukemia Dahkki Bruno Quesnel, Claude Preudhomme, N Philippe, M Vanrumbeke, Isabelle Dervite, JL Laï, F Bauters, Eric Wattel, Pierre Fenaux
Almmustuhtton 1995Artigo -
7
Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France Dahkki Catherine Nisse, J. M. Haguenoer, Bruno Grandbastien, Claude Preudhomme, B. Fontaine, Jeanne Marie Brillet, Regis Lejeune, Pierre Fenaux
Almmustuhtton 2001Artigo -
8
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment Dahkki Catherine Roche‐Lestienne, Valérie Soenen, Nathalie Grardel, Jean-Luc Laı̈, N Philippe, Thierry Façon, Pierre Fenaux, Claude Preudhomme
Almmustuhtton 2002Artigo -
9
Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing Dahkki Mathieu Giraud, Mikaël Salson, Marc Duez, Céline Villenet, Sabine Quief, Aurélie Caillault, Nathalie Grardel, Christophe Roumier, Claude Preudhomme, Martin Figeac
Almmustuhtton 2014Artigo -
10
Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia Dahkki Aline Renneville, Nicolas Boissel, Virginie Zurawski, Laura Llopis, Valéria Biggio, Olivier Nibourel, N Philippe, Xavier Thomas, Hervé Dombret, Claude Preudhomme
Almmustuhtton 2009Artigo -
11
Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion Dahkki Yvon Sterkers, Claude Preudhomme, Jean-Luc Laı̈, Jean‐Loup Demory, Marie‐Thérèse Caulier, Eric Wattel, Dominique Bordessoule, F Bauters, Pierre Fenaux
Almmustuhtton 1998Artigo -
12
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and im... Dahkki Catherine Roche‐Lestienne, Lauréline Deluche, Sélim Corm, Isabelle Tigaud, Sami Joha, N Philippe, Sandrine Geffroy, Jean‐Luc Laï, Franck‐Emmanuel Nicolini, Claude Preudhomme
Almmustuhtton 2008Artigo -
13
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial Dahkki Christophe Willekens, Odile Blanchet, Aline Renneville, Pascale Cornillet‐Lefèbvre, Cécile Pautas, Romain Guièze, Norbert Ifrah, Hervé Dombret, Éric Jourdan, Claude Preudhomme, Nicolas Boissel
Almmustuhtton 2015Artigo -
14
Genetic typing of <i>CBL</i>, <i>ASXL1</i>, <i>RUNX1</i>, <i>TET2</i> and <i>JAK2</i> in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomono... Dahkki B. Perez, Olivier Kosmider, Bruno Cassinat, Aline Renneville, Julie Lachenaud, Sophie Kaltenbach, Yves Bertrand, André Baruchel, Christine Chomienne, Michaëla Fontenay, Claude Preudhomme, Hélène Cavé
Almmustuhtton 2010Artigo -
15
Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia Dahkki Heriberto Bruzzoni‐Giovanelli, Juan R. González, François Sigaux, Bruno O. Villoutreix, Jean Michel Cayuela, Joëlle Guilhot, Claude Preudhomme, François Guilhot, Jean‐Luc Poyet, Philippe Rousselot
Almmustuhtton 2015Artigo -
16
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML Dahkki Daniel J. Pearce, David Taussig, Kazem Zibara, Lan‐Lan Smith, Christopher M. Ridler, Claude Preudhomme, Bryan D. Young, A. Z. S. Rohatiner, T. Andrew Lister, Dominique Bonnet
Almmustuhtton 2005Artigo -
17
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA) Dahkki Claude Preudhomme, C. Sagot, Nicolas Boissel, Jean‐Michel Cayuela, Isabelle Tigaud, Stéphane de Botton, Xavier Thomas, Emmanuel Raffoux, Charlotte Lamandin, Sylvie Castaigné, Pierre Fenaux, Hervé Dombret
Almmustuhtton 2002Artigo -
18
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study Dahkki Patricia Marino, Rajae Touzani, Lionel Perrier, Étienne Rouleau, Dede Sika Kossi, Zhaomin Zou, Nathanaël Charrier, Nicolas Goardon, Claude Preudhomme, Isabelle Durand‐Zaleski, Isabelle Borget, Sandrine Baffert
Almmustuhtton 2018Artigo -
19
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia Dahkki Jean‐Emmanuel Bibault, Martin Figeac, Nathalie Hélevaut, Céline Rodriguez, Sabine Quief, Shéhérazade Sebda, Aline Renneville, Olivier Nibourel, Philippe Rousselot, Bérengère Gruson, Hervé Dombret, Sylvie Castaigné, Claude Preudhomme
Almmustuhtton 2015Artigo -
20
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder Dahkki Claude Preudhomme, Aline Renneville, Violaine Bourdon, N Philippe, Catherine Roche‐Lestienne, Nicolas Boissel, Nathalie Dhédin, Jean‐Marie André, Pascale Cornillet‐Lefèbvre, André Baruchel, Julien Mozziconacci, Hagay Sobol
Almmustuhtton 2009Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Medicine
Gene
Genetics
Internal medicine
Myeloid leukemia
Leukemia
Oncology
Cancer research
Mutation
Immunology
Bone marrow
Myeloid
Chromosome
Stem cell
Gastroenterology
Myelodysplastic syndromes
Karyotype
Biochemistry
Haematopoiesis
NPM1
CEBPA
Chemotherapy
RUNX1
Cancer
Confidence interval
Gene expression
Imatinib
Cytogenetics
Germline